4.2 nSTEMI guidelines:
Patients diagnosed with an nSTEMI are immediately offered pharmaceutical intervention (aspirin, heparin, fondaparinux or antithrombin) and stratified into low, medium or high-risk groups using an established scoring system such as the GRACE score.[32] The GRACE score estimates the admission to 6 month mortality based on age, blood pressure, creatinine levels as well as other criteria.[36] Patients with low risk are managed conservatively with continued monitoring. Intermediate and higher risk patients are offered clopidogrel and assessed for reperfusion surgery and given a SYNTAX score. Similar to the management of STEMI, PPCI is the favoured option for reperfusion in the vast majority of patients. CABG is only preferred when PCI is contraindicated in patients with a high SYNTAX score.[37]